The serotonin system in autism spectrum disorder: From biomarker to animal models
about
New Therapeutic Options for Autism Spectrum Disorder: Experimental EvidencesUpdated report on tools to measure outcomes of clinical trials in fragile X syndrome.Epigenetic adaptation of the placental serotonin transporter gene (SLC6A4) to gestational diabetes mellitusOf rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies.Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs.Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.Exposure to endocrine disrupting chemicals and neurodevelopmental alterations.Association of Rigid-Compulsive Behavior with Functional Constipation in Autism Spectrum Disorder.Generating human serotonergic neurons in vitro: Methodological advances.The BTBR mouse model of idiopathic autism - Current view on mechanisms.A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure.Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.An interplay between the serotonin transporter (SERT) and 5-HT receptors controls stimulus-secretion coupling in sympathoadrenal chromaffin cells.Serotonin in the Frontal Cortex: A Potential Therapeutic Target for Neurological DisordersTightening the Case for Gut Microbiota in Autism-Spectrum Disorder.Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism.Autism Spectrum Disorder in Males with Sex Chromosome Aneuploidy: XXY/Klinefelter Syndrome, XYY, and XXYY.The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?Serotonin neuron abnormalities in the BTBR mouse model of autism.16p11.2 deletion syndrome mice perseverate with active coping response to acute stress - rescue by blocking 5-HT2A receptors.Altered Cav1.2 function in the Timothy syndrome mouse model produces ascending serotonergic abnormalities.Increased serum midkine levels in autism spectrum disorder patients.The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain.Oxytocin and Prader-Willi Syndrome.Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.Opposing Cholinergic and Serotonergic Modulation of Layer 6 in Prefrontal Cortex.Maternal protein restriction during gestation and lactation in the rat results in increased brain levels of kynurenine and kynurenic acid in their adult offspring.Maturation, Refinement, and Serotonergic Modulation of Cerebellar Cortical Circuits in Normal Development and in Murine Models of Autism.Monoamine oxidase-A and B activities in the cerebellum and frontal cortex of children and young adults with autism.Is there sexual dimorphism of hyperserotonemia in autism spectrum disorder?The Effects of Housing Density on Social Interactions and Their Correlations with Serotonin in Rodents and Primates.Analysis of neuroanatomical differences in mice with genetically modified serotonin transporters assessed by structural magnetic resonance imaging.Common Defects of Spine Dynamics and Circuit Function in Neurodevelopmental Disorders: A Systematic Review of Findings From in Vivo Optical Imaging of Mouse Models.Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder.Alexithymia and Autism Spectrum Disorder: A Complex RelationshipMultimodal sensory processing inp38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouseDeep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model
P2860
Q26771762-99BCCEE6-E502-480D-BC77-5B49093DC8CCQ33785978-F5791BDC-06D1-4265-882F-79EA3145AF7EQ33834768-8606B5F3-9594-4240-B6A0-521230AEC921Q37058701-AB710AD5-2D80-47EE-BCB6-8DE23F628774Q37673635-ABC50C62-0FB1-4E69-AC3D-550A3996F8DDQ38653394-03F0B1A7-ACC4-4173-8A2C-B6C277175766Q38793435-A7C75876-0694-458E-92DE-6B3BD8DE1C1FQ38816381-5B668860-BBE9-4722-BA11-1D226A293ACEQ38861122-BEB3F31F-9075-421B-AD29-6C0AD7724F8BQ38909976-8866945F-2DD2-4A44-9C6F-07FDBADC475DQ38975150-5A6AE4DB-D9D8-4CD3-9C4D-D2E3943706E1Q38975802-CFB1C881-5C4E-4FC1-91B0-19E71013E741Q39141290-90CA911A-1E30-4844-B7D0-A60324B559B6Q39464602-11E3169B-EF1F-47E8-AD6E-6945045AF49CQ39470065-AA84180E-0F41-41BE-AA04-0933E9DCA3C2Q41151173-E07562B2-0AEA-40AA-848D-B169BA35D56BQ42319045-2A614400-AA87-41B5-A7EE-7527867497B0Q42651339-9D28281E-B33D-4173-BF42-19E621EBA2D6Q44745976-3FDA439C-FA7E-439B-8873-A70B2BDC0594Q47110293-16392557-0323-4EAE-A1D6-690AF62B3B2CQ47137996-02D0215D-2689-498B-9EB4-0A738ADE0AF5Q47248416-668464B5-ACED-4C70-B648-7E2B903FA56AQ47251404-81A55369-921B-4A11-989C-599B19956EBEQ47429837-D8D98640-A4F8-4FAF-81ED-1FE74CBFB68FQ47643932-8F508E42-E145-4ECE-A23E-A638B4C9C862Q47675924-C9CE5C15-DAD6-4010-8AEA-5072E28656CCQ47753817-FF534ED0-FF63-4D00-978A-D3711E51E74DQ47849364-61DFDEAD-8A0D-444A-B26A-539FB2767BADQ47902256-EAC49C2F-A670-456F-8F31-ED07A643A923Q48089818-7754144E-AD30-4CE2-901F-C5A72477B3B5Q48284566-02AAF50F-A660-49D7-BA35-0285E8749BC8Q48286710-749D8A94-D18B-49F8-86F2-9B56984E3AA3Q50285655-A9CBA5EF-1070-4097-B5D3-FC001A15F216Q52590731-FEE07FC0-1B9B-4897-9225-E5DE1DE58789Q55474439-2FBC0DB9-0208-4C31-B80F-99081224692DQ55511344-D5A61835-81DB-42CB-9AAD-E52478B85954Q57040204-4AABAD55-243C-40DE-8864-AD23BA289EEDQ57243057-D44BD023-EDAE-42B5-A563-9AA18F5BB006Q57295974-975BCBA6-EECD-48A8-B94E-C07F1FA97F70Q58716287-C4DB93E0-D9EA-4BCB-9BAB-76703F3215CE
P2860
The serotonin system in autism spectrum disorder: From biomarker to animal models
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The serotonin system in autism spectrum disorder: From biomarker to animal models
@ast
The serotonin system in autism spectrum disorder: From biomarker to animal models
@en
The serotonin system in autism spectrum disorder: From biomarker to animal models
@nl
type
label
The serotonin system in autism spectrum disorder: From biomarker to animal models
@ast
The serotonin system in autism spectrum disorder: From biomarker to animal models
@en
The serotonin system in autism spectrum disorder: From biomarker to animal models
@nl
prefLabel
The serotonin system in autism spectrum disorder: From biomarker to animal models
@ast
The serotonin system in autism spectrum disorder: From biomarker to animal models
@en
The serotonin system in autism spectrum disorder: From biomarker to animal models
@nl
P2860
P921
P1433
P1476
The serotonin system in autism spectrum disorder: From biomarker to animal models
@en
P2093
A M J Anacker
C L Muller
P2860
P356
10.1016/J.NEUROSCIENCE.2015.11.010
P407
P577
2016-05-03T00:00:00Z